First-Line Treatment of Chronic Lymphocytic Leukemia

This protocol addresses the first-line clinical approach to Chronic lymphocytic leukemia (CLL). Selecting the appropriate initial regimen depends on the patient's specific clinical profile, and the full protocol provides the structured, evidence-based framework for that decision.

The complete regimen — including the treatment approach and the clinical goals that define response — is available through the link below.